PROGRESSION OF CHRONIC-RENAL-FAILURE IN A HISTORICAL GROUP OF PATIENTS WITH NEPHROPATHIC CYSTINOSIS

被引:31
作者
MANZ, F
GRETZ, N
BROYER, M
GEISERT, J
GROTE, K
WEBER, HP
HENNEMANN, H
BREMER, HJ
MICHALK, D
FELDHOFF, C
PISTOR, K
GESCHOLLBAUER, B
SCHINDERA, F
WOLF, H
BENDERGOTZE, C
GRUTTNER, R
BRODEHL, J
EHRICH, JHH
HARMS, E
SCHARER, K
SCHMIDT, H
BULLA, M
SCHULTEWISSERMANN, H
BRANDIS, M
WILLENBOCKEL, U
ENDRES, W
KLARE, B
DIEKMANN, L
RAU, J
AUGUSTIN, R
HAGGE, W
LEUPOLD, D
LOHR, H
GEKLE, D
OTT, F
VERRIERJONES, K
BARRATT, TM
CHANTLER, C
DILLON, MJ
HAYCOCK, GB
OLIVEIRA, A
CALLIS, L
EGLI, F
FANCONI, A
机构
[1] Research Institute of Child Nutrition, Dortmund, D-44225
[2] Clinic of Nephrology, Klinikum Mannheim, University of Heidelberg, Mannheim
关键词
CYSTINOSIS; CHRONIC RENAL FAILURE; SERUM CREATININE; SIBLINGS;
D O I
10.1007/BF00856532
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In a historical group of 205 patients with infantile or adolescent cystinosis treated without cysteamine, the rate of deterioration of renal function was analysed retrospectively. Patient survival curves and renal survival data are presented. Longitudinal data of serum creatinine values (n = 3280) in 157 patients were plotted for each patient, smoothed by the method of the running medians and grouped into 12 serum creatinine classes. In every patient the age at the last smoothed serum creatinine value observed in each serum creatinine class was determined. These virtual age values were then summarized per serum creatinine class, expressed as median and centiles and plotted, thus describing the ''natural'' course of the disease. In 9 pairs of affected siblings the rate of progression showed a median difference of about 12 months. Our data describe the ''natural'' course of nephropathic cystinosis and can be used as a prognostic aid for recently detected patients. The data can also be applied for the assessment of the influence of new therapeutic strategies on the rate of progression of renal failure in cystinotic patients.
引用
收藏
页码:466 / 471
页数:6
相关论文
共 29 条
[1]  
Schulman J.D., Cystinosis, Prog Clin Biol Res, 305, pp. 137-144, (1989)
[2]  
Manz F., Gretz N., Cystinosis in the Federal Republic of Germany: coordination and analysis of the data, J Inherited Metab Dis, 8, pp. 2-4, (1985)
[3]  
Schmidt H., Lutz P., Bickel H., Wertbeurteilung der diätetischen Behandlung der Cystinose, Monatsschr Kinderheilkd, 121, pp. 171-173, (1973)
[4]  
Schneider J.A., Schlesselman J.J., Mendoza S.A., Orloff S., Thoene J.G., Kroll W.A., Godfrey A.D., Schulman J.D., Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis, N Engl J Med, 300, pp. 756-759, (1979)
[5]  
Yudkoff M., Foreman J.W., Segal S., Effects of cysteamine therapy in nephropathic cystinosis, N Engl J Med, 304, pp. 141-145, (1981)
[6]  
Gahl W.A., Reed G.F., Thoene J.G., Schulman J.D., Rizzo W.B., Jonas A.J., Denman D.W., Schlesselman J.J., Corden B.J., Schneider J.A., Cysteamine therapy for children with nephropathic cystinosis, N Engl J Med, 316, pp. 971-977, (1987)
[7]  
Gahl W.A., Schneider J.A., Schulman J.D., Thoene J.G., Reed G.F., Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine, Pediatr Nephrol, 4, pp. 129-135, (1990)
[8]  
Gretz N., Manz F., Strauch M., Predictability of the progression of chronic renal failure, Kidney Int, 24, pp. S2-S5, (1983)
[9]  
Gretz N., Meisinger E., Strauch M., Experimental models to assess the influence of low protein diets on the progression of chronic renal failure, Contrib Nephrol, 53, pp. 7-20, (1986)
[10]  
Manz F., Scharer K., Long-term management of inherited renal tubular disorders, Klin Wochenschr, 60, pp. 1115-1125, (1982)